581 related articles for article (PubMed ID: 17705359)
1. Synthesis and in vivo evaluation of fluorine-18 and iodine-123 labeled 2beta-carbo(2-fluoroethoxy)-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane as a candidate serotonin transporter imaging agent.
Plisson C; Stehouwer JS; Voll RJ; Howell L; Votaw JR; Owens MJ; Goodman MM
J Med Chem; 2007 Sep; 50(19):4553-60. PubMed ID: 17705359
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.
Goodman MM; Chen P; Plisson C; Martarello L; Galt J; Votaw JR; Kilts CD; Malveaux G; Camp VM; Shi B; Ely TD; Howell L; McConathy J; Nemeroff CB
J Med Chem; 2003 Mar; 46(6):925-35. PubMed ID: 12620070
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.
Plisson C; McConathy J; Martarello L; Malveaux EJ; Camp VM; Williams L; Votaw JR; Goodman MM
J Med Chem; 2004 Feb; 47(5):1122-35. PubMed ID: 14971892
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, radiosynthesis, and biological evaluation of carbon-11 labeled 2beta-carbomethoxy-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.
Stehouwer JS; Jarkas N; Zeng F; Voll RJ; Williams L; Owens MJ; Votaw JR; Goodman MM
J Med Chem; 2006 Nov; 49(23):6760-7. PubMed ID: 17154506
[TBL] [Abstract][Full Text] [Related]
5. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
Huang Y; Bae SA; Zhu Z; Guo N; Roth BL; Laruelle M
J Med Chem; 2005 Apr; 48(7):2559-70. PubMed ID: 15801845
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of carbon-11-labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-iodoethenyl)phenyl]nortropane as a potential radioligand for imaging the serotonin transporter by PET.
Plisson C; Jarkas N; McConathy J; Voll RJ; Votaw J; Williams L; Howell LL; Kilts CD; Goodman MM
J Med Chem; 2006 Feb; 49(3):942-6. PubMed ID: 16451060
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, radiolabeling and preliminary in vivo evaluation of [18F]FE-PE2I, a new probe for the dopamine transporter.
Schou M; Steiger C; Varrone A; Guilloteau D; Halldin C
Bioorg Med Chem Lett; 2009 Aug; 19(16):4843-5. PubMed ID: 19577467
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands.
Jarkas N; Voll RJ; Williams L; Votaw JR; Owens M; Goodman MM
J Med Chem; 2008 Jan; 51(2):271-81. PubMed ID: 18085744
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo and in vivo evaluation of [18F]PR04.MZ in rodents: a selective dopamine transporter imaging agent.
Riss PJ; Debus F; Hummerich R; Schmidt U; Schloss P; Lueddens H; Roesch F
ChemMedChem; 2009 Sep; 4(9):1480-7. PubMed ID: 19588472
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biodistribution, and primate imaging of fluorine-18 labeled 2beta-carbo-1'-fluoro-2-propoxy-3beta-(4-chlorophenyl)tr opanes. Ligands for the imaging of dopamine transporters by positron emission tomography.
Xing D; Chen P; Keil R; Kilts CD; Shi B; Camp VM; Malveaux G; Ely T; Owens MJ; Votaw J; Davis M; Hoffman JM; BaKay RA; Subramanian T; Watts RL; Goodman MM
J Med Chem; 2000 Feb; 43(4):639-48. PubMed ID: 10691690
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.
Stehouwer JS; Jarkas N; Zeng F; Voll RJ; Williams L; Camp VM; Malveaux EJ; Votaw JR; Howell L; Owens MJ; Goodman MM
J Med Chem; 2008 Dec; 51(24):7788-99. PubMed ID: 19053782
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 (N-fluoroalkyl) labeled 2beta-carbomethoxy-3beta-(4'-(3-furyl)phenyl)tropanes and -nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.
Stehouwer JS; Plisson C; Jarkas N; Zeng F; Voll RJ; Williams L; Martarello L; Votaw JR; Tamagnan G; Goodman MM
J Med Chem; 2005 Nov; 48(22):7080-3. PubMed ID: 16250668
[TBL] [Abstract][Full Text] [Related]
13. Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain.
Harada N; Ohba H; Fukumoto D; Kakiuchi T; Tsukada H
Synapse; 2004 Oct; 54(1):37-45. PubMed ID: 15300883
[TBL] [Abstract][Full Text] [Related]
14. 18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters.
Goodman MM; Kilts CD; Keil R; Shi B; Martarello L; Xing D; Votaw J; Ely TD; Lambert P; Owens MJ; Camp VM; Malveaux E; Hoffman JM
Nucl Med Biol; 2000 Jan; 27(1):1-12. PubMed ID: 10755640
[TBL] [Abstract][Full Text] [Related]
15. N-(3-lodoprop-2E-enyl)-2beta-carbomethoxy-3beta-(3',4'-dichloro phenyl)nortropane (beta-CDIT), a tropane derivative: pharmacological characterization as a specific ligand for the dopamine transporter in the rodent brain.
Garreau L; Emond P; Belzung C; Guilloteau D; Frangin Y; Besnard JC; Chalon S
J Pharmacol Exp Ther; 1997 Jul; 282(1):467-74. PubMed ID: 9223589
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biodistribution of [18F]FE@CIT, a new potential tracer for the dopamine transporter.
Mitterhauser M; Wadsak W; Mien LK; Hoepping A; Viernstein H; Dudczak R; Kletter K
Synapse; 2005 Feb; 55(2):73-9. PubMed ID: 15529336
[TBL] [Abstract][Full Text] [Related]
17. Semi-automated preparation of the dopamine transporter ligand [(18)F]FECNT for human PET imaging studies.
Voll RJ; McConathy J; Waldrep MS; Crowe RJ; Goodman MM
Appl Radiat Isot; 2005 Sep; 63(3):353-61. PubMed ID: 15985372
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.
Stehouwer JS; Daniel LM; Chen P; Voll RJ; Williams L; Plott SJ; Votaw JR; Owens MJ; Howell L; Goodman MM
J Med Chem; 2010 Aug; 53(15):5549-57. PubMed ID: 20597489
[TBL] [Abstract][Full Text] [Related]
19. In vivo evaluation of [¹²³I]mZIENT as a SPECT radioligand for the serotonin transporter.
Batis J; Barret O; Alagille D; Koren AO; Stehouwer JS; Cosgrove K; Goodman M; Seibyl J; Tamagnan G
Nucl Med Biol; 2012 Nov; 39(8):1137-41. PubMed ID: 23084043
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and radiopharmacological characterization of 2beta-carbo-2'-[18F]fluoroethoxy-3beta-(4-bromo-phenyl)tropane ([18F]MCL-322) as a PET radiotracer for imaging the dopamine transporter (DAT).
Wuest F; Berndt M; Strobel K; van den Hoff J; Peng X; Neumeyer JL; Bergmann R
Bioorg Med Chem; 2007 Jul; 15(13):4511-9. PubMed ID: 17467995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
